companies innovating in obesity treatment glp-1 drugs 2025 Top and Diabetes Medications Transforming U.S. Pharma Market Companies seek a second obesity
Description
sixteenth ed
For patients with BMI 35 kg/m (regardless of comorbidities) or BMI 30-34.9 kg/m with metabolic disease, bariatric surgery consultation may be appropriate, according to 2022 American Society for Metabolic and Bariatric Surgery guidelines
.svg?mw=810&hash=BF44E6E0F79CC8AF56261DA23D63DE29)
doi: 10.1016/j.ahj.2011.08.004
Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapyA consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
They may reduce inflammation, for example, which is a known driver of cancer
